Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Musselli · SciRah

Researcher profile · Semantic Scholar

C. Musselli

Share profile

C. Musselli — researcher profile on SciRah

h-index: 17
Works: 39
Citations: 1,663

Most-cited papers

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial
T. Gilewski, G. Ragupathi, S. Bhuta, L. J. Williams +10 more
2001Proceedings of the National Academy of Sciences of the United States of America203 citations Open access
Semantic Scholar
Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
S. Slovin, G. Ragupathi, C. Musselli, K. Olkiewicz +7 more
2003Journal of Clinical Oncology170 citations
Semantic Scholar
Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3‐lactone‐KLH conjugate plus immunological adjuvant QS‐21
G. Ragupathi, M. Meyers, S. Adluri, L. Howard +2 more
2000International Journal of Cancer126 citations Open access
Semantic Scholar
Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.
Soo Kie Kim, G. Ragupathi, C. Musselli, Sun-Ju Choi +2 more
1999Vaccine118 citations
Semantic Scholar
Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
S. Slovin, G. Ragupathi, C. Musselli, C. Fernandez +5 more
2005Cancer Immunology and Immunotherapy117 citations Open access
Semantic Scholar
T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.
S. Schaed, V. Klimek, K. Panageas, C. Musselli +7 more
2002Clinical Cancer Research109 citations
Semantic Scholar
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
V. Werth, R. Furie, J. Romero-Díaz, S. Navarra +15 more
2022New England Journal of Medicine97 citations Open access
Semantic Scholar
Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
M. Dickler, G. Ragupathi, Nancy X. Liu, C. Musselli +6 more
1999Clinical Cancer Research92 citations
Semantic Scholar
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
R. Furie, R. van Vollenhoven, K. Kalunian, S. Navarra +9 more
2022New England Journal of Medicine89 citations Open access
Semantic Scholar
Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience
C. Musselli, P. Livingston, G. Ragupathi
2001Journal of Cancer Research and Clinical Oncology83 citations Open access
Semantic Scholar
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.
A. Wald, D. Koelle, K. Fife, T. Warren +6 more
2011Vaccine81 citations
Semantic Scholar
Antibodies against Tumor Cell Glycolipids and Proteins, but Not Mucins, Mediate Complement-Dependent Cytotoxicity1
G. Ragupathi, Nancy X. Liu, C. Musselli, Shemeeakah Powell +2 more
2005Journal of Immunology77 citations Open access
Semantic Scholar
Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1
C. Musselli, G. Ragupathi, T. Gilewski, K. Panageas +2 more
2002International Journal of Cancer75 citations
Semantic Scholar
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops
C. Barzegar, R. Meazza, R. Pereno, C. Pottin-Clemenceau +11 more
1998Oncogene50 citations Open access
Semantic Scholar
A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
An-Nie X. Y. Mo, C. Musselli, Hong D. Chen, J. Pappas +7 more
2011Vaccine46 citations
Semantic Scholar
Autoimmune and Antitumor Consequences of Antibodies Against Antigens Shared by Normal and Malignant Tissues
P. Livingston, G. Ragupathi, C. Musselli
2000Journal of Clinical Immunology31 citations
Semantic Scholar
OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
V. Werth, R. Furie, J. Romero-Díaz, S. Navarra +13 more
2020Annals of the Rheumatic Diseases20 citations Open access
Semantic Scholar
Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells
Sarah Cappello, Nancy X. Liu, C. Musselli, F. Brezicka +2 more
1999Cancer Immunology and Immunotherapy14 citations Open access
Semantic Scholar
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
J. Merola, Wenting Wang, C. Wager, S. Hamann +10 more
2021Lupus Science and Medicine10 citations Open access
Semantic Scholar
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer
M. Setti, D. Bignardi, A. Ballestrero, F. Ferrando +7 more
1999Cancer Immunology and Immunotherapy10 citations Open access
Semantic Scholar
[The immunological activity of corticosteroids].
M. Scudeletti, C. Musselli, L. Lanza, L. Peirano +2 more
1996Recenti progressi in medicina10 citations
Semantic Scholar
SAT0222 BIIB059, a monoclonal antibody targeting BDCA2, shows evidence of biological activity and early clinical proof of concept in subjects with active cutaneous le
R. Furie, V. Werth, J. Merola, Taylor L. Reynolds +8 more
20178 citations Open access
Semantic Scholar
Immunogenicity of a Fucosyl-GM 1-Keyhole Limpet Hemocyanin Conjugate Vaccine in Patients with Small Cell Lung Cancer 1
M. Dickler, G. Ragupathi, Nancy X. Liu, C. Musselli +6 more
19998 citations
Semantic Scholar
In vivo hemopoietic activity of thymic extract 'Thymustimulin' in aged healthy humans.
E. Balleari, Silvana Timitilli, C. Musselli, Riccardo Ghio
1992Thymus6 citations
Semantic Scholar
Journal of Immune Based Therapies and Vaccines Antigenized Antibodies Expressing Vβ8.2 Tcr Peptides Immunize against Rat Experimental Allergic Encephalomyelitis
C. Musselli, Svetlana Daverio-Zanetti, M. Zanetti
6 citations
Semantic Scholar
1081 BIIB059, a monoclonal antibody targeting BDCA2, decreases Type I Interferon-related genes transcriptional activity in subjects with systemic lupus erythematosus (SLE) and active cutaneous LE (CLE)
V. Werth, J. Merola, R. Furie, T. Reynolds +9 more
20183 citations Open access
Semantic Scholar
Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: Evidence of an inhibitory effect of autologous T lymphocytes
E. Balleari, Silvana Timitilli, F. Puppo, L. Gaffuri +4 more
1991Annals of Hematology3 citations
Semantic Scholar
POS0184 EFFICACY OF BIIB059 ON SKIN MANIFESTATIONS IN PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN THE PHASE 2 LILAC STUDY (PART A)
R. van Vollenhoven, R. Furie, V. Werth, K. Kalunian +4 more
2022Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
POS0699 GREATER REDUCTION IN CLASI-A SCORES ACHIEVED WITH BIIB059 VERSUS PLACEBO INDEPENDENTLY OF DISEASE SEVERITY AT BASELINE
V. Werth, R. Furie, K. Kalunian, R. van Vollenhoven +9 more
2021Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
POS0698 BIIB059 DEMONSTRATED A CONSISTENT THERAPEUTIC EFFECT ON SRI-4 RESPONSE ACROSS SUBGROUPS OF PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN THE LILAC PHASE 2 STUDY
R. van Vollenhoven, R. Furie, K. Kalunian, S. Navarra +7 more
20211 citations Open access
Semantic Scholar
SAT0235 BIIB059, a monoclonal antibody targeting BCDA2 shows safety, tolerability, pharmacokinetics, pharmacodynamics in healthy volunteer subjects
D. Martin, L. Stevenson, P. Prasad, K. Smirnakis +6 more
20171 citations Open access
Semantic Scholar
Fully S ynthetic C arbohydrate-Bas ed V accines i n B iochemically Relapsed P rostate C ancer: C linical T rial R esults With - N -Acetylgalactosa mine- O -Serine/Threonin e Conjugate V accine
S. Slovin, G. Ragupathi, C. Musselli, K. Olkiewicz +7 more
20031 citations
Semantic Scholar
PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash
R. V. van Vollenhoven, R. Furie, K. Kalunian, VP Werth +5 more
2022Thursday 06 October 2022 from 13:00 to 14:100 citations Open access
Semantic Scholar
POS0713 BIIB059 EFFICACY IN PARTICIPANTS WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE): SUBGROUP ANALYSIS OF PARTICIPANTS ACHIEVING CLEAR/ALMOST CLEAR DISEASE ACTIVITY FROM PART B OF THE TWO-PART PHASE 2 LILAC STUDY
V. Werth, R. Furie, F. Nyberg, X. Huang +3 more
2022Annals of the Rheumatic Diseases0 citations Open access
Semantic Scholar
27475 Efficacy of the BIIB059 monoclonal antibody against BDCA2 in active cutaneous lupus erythematosus (CLE): Subgroup analyses of participants with or without systemic LE (SLE) and with different levels of disease activity
V. Werth, R. Furie, F. Nyberg, H. Sofen +7 more
20210 citations
Semantic Scholar
FRI0315 Safety, tolerability, pharmacokinetic and pharmacodynamic effects of biib059, a monoclonal antibody targeting bdca2 following intravenous (IV) and subcutaneous (SC) single or multiple doses administration in healthy volounteers (HV) and subjects with active systemic lupus erythematosus (SLE)
C. Barbey, Himanshu Naik, C. Musselli, R. Christmann +4 more
2018FRIDAY, 15 JUNE 20180 citations Open access
Semantic Scholar
1096 Non-invasive tape sampling reveals a type I interferon RNA signature in cutaneous lupus erythematosus that distinguishes affected from unaffected and healthy volunteer skin
J. Merola, C. Wager, S. Hamann, X. Zhang +9 more
20180 citations Open access
Semantic Scholar
AB1156 The descriptive epidemiology of cutaneous lupus erythematosus in three large u.s. administrative databases, 2010-2014
S. Hall, L. Li, S. Eaton, C. Musselli +1 more
20170 citations Open access
Semantic Scholar
Emerging clinical trial design concepts for therapeutic cancer vaccines
C. Musselli, L. Isakov, K. Wentworth
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Barbey×15
Invite
C. Barbey — researcher profile on SciRah
N. Franchimont×15
Invite
N. Franchimont — researcher profile on SciRah
G. Ragupathi×12
Invite
G. Ragupathi — researcher profile on SciRah
P. Livingston×11
Invite
P. Livingston — researcher profile on SciRah

×8

Invite

R. Furie — researcher profile on SciRah

Invite

H. Carroll — researcher profile on SciRah

Invite

X. Huang — researcher profile on SciRah

Invite

V. Werth — researcher profile on SciRah

R. van Vollenhoven×6

Invite

R. van Vollenhoven — researcher profile on SciRah

Invite

D. Rabah — researcher profile on SciRah

J. Romero-Díaz×5

Invite

J. Romero-Díaz — researcher profile on SciRah

Invite

S. Navarra — researcher profile on SciRah